Home » Stocks » QLI

Qilian International Holding Group Limited (QLI)

Qilian International will go public soon, but the exact IPO date is still unknown.
Stock Price: $5.00 - $7.00
Current IPO price range

Stock Price Chart

Key Info

Market Cap 210.00M
Revenue (ttm) 46.70M
Net Income (ttm) 5.07M
Shares Out 35.00M
EPS (ttm) 0.14
PE Ratio 41.44
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

More Stats

Market Cap 210.00M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 35.00M
Float n/a
EPS (basic) n/a
EPS (diluted) 0.14
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.41%
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio 41.44
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.50
PB Ratio n/a
Revenue 46.70M
Operating Income n/a
Net Income 5.07M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin 10.85%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018
Revenue46.1050.37
Revenue Growth-8.48%-
Net Income / Loss5.915.20
Earnings Growth13.57%-
Numbers in millions USD.

Company Profile

Company Details

Full Name Qilian International Holding Group Limited
Country China
Employees 279
CEO Zhanchang Xin

Stock Information

Ticker Symbol QLI
Stock Exchange NYSE
Unique Identifier NYSE: QLI
IPO Date Pending

Description

Qilian International is a pharmaceutical and chemical company based in China that focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers. We independently developed Gan Di Xin® and Ahan® Antibacterial Paste within our research and development department. Our products are sold in more than 20 provinces in China.